Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Jespersen, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 118 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. de Maat, MPM; Dooijewaard, G; Meijer, P; Binder, BR; Keber, D; Risberg, B; Kluft, C; Jespersen, J
      Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study

      BLOOD COAGULATION & FIBRINOLYSIS
    2. Olsen, AK; Larsen, LF; Bladbjerg, EM; Hansen, AK; Jespersen, J; Marckmann, P
      A high-fat meal does not activate blood coagulation factor VII in minipigs

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Myrup, B; Rossing, P; Jensen, T; Parving, HH; Holmer, G; Gram, J; Kluft, C; Jespersen, J
      Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    4. Kayser, M; Krawczak, M; Excoffier, L; Dieltjes, P; Corach, D; Pascali, V; Gehrig, C; Bernini, LF; Jespersen, J; Bakker, E; Roewer, L; de Knijff, P
      An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations

      AMERICAN JOURNAL OF HUMAN GENETICS
    5. Petersen, KR; Jorgensen, M; Vinberg, N; Gram, J; Skouby, SO; Tonnesen, KH; Jespersen, J
      Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives

      FIBRINOLYSIS & PROTEOLYSIS
    6. Bladbjerg, EM; Munster, AM; Marckmann, P; Keller, N; Jespersen, J
      Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    7. Bladbjerg, EM; Larsen, LF; Ostergaard, P; Jespersen, J
      In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy

      BLOOD COAGULATION & FIBRINOLYSIS
    8. Gram, J; Bladbjerg, EM; Moller, L; Sjol, A; Jespersen, J
      Tissue-type plasminogen activator and C-reactive protein in acute coronaryheart disease. A nested case-control study

      JOURNAL OF INTERNAL MEDICINE
    9. Sidelmann, JJ; Gram, J; Jespersen, J; Kluft, C
      Fibrin clot formation and lysis: Basic mechanisms

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    10. Nielsen, JD; Holm-Nielsen, A; Jespersen, J; Vinther, CC; Settgast, IW; Gram, J
      The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy - A prospective, randomized, double-blind, placebo-controlled study

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    11. Bladbjerg, EM; Gram, J; Jespersen, J
      Plasma concentrations of blood coagulation factor VII measured by immunochemical and amidolytic methods

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    12. Larsen, LF; Marckmann, P; Bladbjerg, EM; Ostergaard, PB; Sidelmann, J; Jespersen, J
      The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    13. Nielsen, JD; Gram, J; Holm-Nielsen, A; Jespersen, J
      Bleeding and activation of coagulation during and after transurethral prostatectomy: importance of the acute-phase response and prostate specific antigen?

      BJU INTERNATIONAL
    14. Gram, J; Munster, AM; Dilling-Hansen, B; Al Lavassani, H; Lahoz, AX; Jespersen, J
      Inhalation/intravenous recombinant tissue plasminogen activator and inhaled heparin in a patient with acute respiratory distress syndrome

      FIBRINOLYSIS & PROTEOLYSIS
    15. Myrup, B; Rossing, P; Jensen, T; Gram, J; Kluft, C; Jespersen, J
      Concentration changes during venous occlusion of proteins with affinity for extracellular matrix in insulin-dependent diabetes mellitus - A sign of vascular damage in patients with diabetic nephropathy?

      FIBRINOLYSIS & PROTEOLYSIS
    16. Gram, J; Jespersen, J; Declerck, P; Kluft, C
      Proposal for a general strategy of standardization of fibrinolysis assays to be used in clinical practice

      FIBRINOLYSIS & PROTEOLYSIS
    17. Bladbjerg, EM; Andersen-Ranberg, K; de Maat, MPM; Kristensen, SR; Jeune, B; Gram, J; Jespersen, J
      Longevity is independent of common variations in genes associated with cardiovascular risk

      THROMBOSIS AND HAEMOSTASIS
    18. Poller, L; van den Besselaar, AMHP; Jespersen, J; Tripodi, A; Houghton, D
      Correction for lack of coincidence of normal and abnormal calibration slopes in ISI determination

      THROMBOSIS AND HAEMOSTASIS
    19. de Maat, MPM; Bladbjerg, EM; Johansen, LG; de Knijff, P; Gram, J; Kluft, C; Jespersen, J
      DNA-Polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit - Is there a relation with the low risk of cardiovascular disease in the Inuit?

      THROMBOSIS AND HAEMOSTASIS
    20. Kluft, C; Meijer, P; Gram, J; Jespersen, J
      Acquired activated protein-C resistance

      LANCET
    21. Jespersen, J
      The price of haste - a comment to Niels Kaergard

      NATIONALOKONOMISK TIDSSKRIFT
    22. Jespersen, J
      The empirical and theorethical foundation of CGE-models

      NATIONALOKONOMISK TIDSSKRIFT
    23. Jespersen, J
      Theory and Reality

      NATIONALOKONOMISK TIDSSKRIFT
    24. Petersen, KR; Christiansen, E; Madsbad, S; Skouby, SO; Andersen, LF; Jespersen, J
      Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives

      CONTRACEPTION
    25. Winkler, UH; Norris, L; Gaspard, U; van Enk, A; Mishell, D; Voncken, D; Klipping, C; David, J; van den Ende, A; Jespersen, J; Pabinger, I; MacRae, K; Crosignani, P; Skouby, S
      An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables - Outline of the protocol

      CONTRACEPTION
    26. Poller, L; van den Besselaar, AMHP; Jespersen, J; Tripodi, A; Houghton, D
      The effect of sample size on fresh plasma thromboplastin ISI determination

      BRITISH JOURNAL OF HAEMATOLOGY
    27. Andersen, LF; Gram, J; Skouby, SO; Jespersen, J
      Effects of hormone replacement therapy on hemostatic cardiovascular risk factors

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    28. Larsen, LF; Jespersen, J; Marckmann, P
      Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    29. MARCKMANN P; BLADBJERG EM; JESPERSEN J
      DIET AND BLOOD-COAGULATION FACTOR-VII - A KEY PROTEIN IN ARTERIAL THROMBOSIS

      European journal of clinical nutrition
    30. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      THE EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) - FIELD STUDIES OF COAGULOMETER EFFECTS ON THE ISI OF ECAA THROMBOPLASTINS

      Thrombosis and haemostasis
    31. BLADBJERG EM; MOLLER L; JESPERSEN J
      IS FACTOR-VI PROTEIN-CONCENTRATION (FVII-AG) A THROMBOTIC RISK INDICATOR

      Thrombosis and haemostasis
    32. DEMAAT MPM; BLADBJERG EM; JOHANSEN LG; GRAM J; JESPERSEN J
      ABSENCE OF PROTHROMBIN MUTATION IN INUIT (GREENLAND ESKIMOS)

      Thrombosis and haemostasis
    33. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      THE EUROPEAN-CONCERTED-ACTION-ON-ANTICOAGULATION (ECAA) EVALUATION OFA SET OF LYOPHILIZED NORMAL PLASMAS TO ESTABLISH THE NORMAL PROTHROMBIN TIME FOR COAGULOMETER SYSTEMS

      Thrombosis and haemostasis
    34. POLLER L; SHIACH CR; MACCALLUM PK; JOHANSEN AM; MUNSTER AM; MAGALHAES A; JESPERSEN J
      MULTICENTER RANDOMIZED STUDY OF COMPUTERIZED ANTICOAGULANT DOSAGE

      Lancet
    35. BLADBJERG EM; MOLLER L; JESPERSEN J
      ASSOCIATION OF FACTOR-VII PROTEIN-CONCENTRATION WITH LIFE-STYLE FACTORS

      Scandinavian journal of clinical & laboratory investigation
    36. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      THE IMPORTANCE OF LIKE TO LIKE ISI CALIBRATIONS WITH FREEZE-DRIED PLASMAS

      Journal of Clinical Pathology
    37. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      A COMPARISON OF LINEAR AND ORTHOGONAL REGRESSION-ANALYSIS FOR LOCAL INR DETERMINATION IN ECAA COAGULOMETER STUDIES

      British Journal of Haematology
    38. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      A COMPARISON OF ARTIFICIALLY-DEPLETED, LYOPHILIZED COUMARIN AND FRESHCOUMARIN PLASMAS IN THROMBOPLASTIN CALIBRATION

      British Journal of Haematology
    39. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      MINIMUM LYOPHILIZED PLASMA REQUIREMENT FOR ISI CALIBRATION

      AJCP. American journal of clinical pathology
    40. Jespersen, J
      Environmental co-operation in the Baltic region

      ENVIRONMENTAL TRANSITION IN NORDIC AND BALTIC COUNTRIES
    41. PEDERSEN OD; GRAM J; JESPERSEN J
      PLASMA RESISTANCE TO ACTIVATED PROTEIN-C REGULATES THE ACTIVATION OF COAGULATION INDUCED BY THROMBOLYSIS IN PATIENTS WITH ISCHEMIC-HEART-DISEASE

      HEART
    42. MARCKMANN P; BLADBJERG EM; JESPERSEN J
      DIETARY FISH-OIL (4 G DAILY) AND CARDIOVASCULAR RISK MARKERS IN HEALTHY-MEN

      Arteriosclerosis, thrombosis, and vascular biology
    43. LARSEN LF; BLADBJERG EM; JESPERSEN J; MARCKMANN P
      EFFECTS OF DIETARY-FAT QUALITY AND QUANTITY ON POSTPRANDIAL ACTIVATION OF BLOOD-COAGULATION FACTOR-VII

      Arteriosclerosis, thrombosis, and vascular biology
    44. DEMAAT MPM; GREEN F; DEKNIJFF P; JESPERSEN J; KLUFT C
      FACTOR-VII POLYMORPHISMS IN POPULATIONS WITH DIFFERENT RISKS OF CARDIOVASCULAR-DISEASE

      Arteriosclerosis, thrombosis, and vascular biology
    45. PEDERSEN OD; GRAM J; JEUNEMAITRE X; BILLAUD E; JESPERSEN J
      DOES LONG-TERM ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AFFECT THE CONCENTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PLASMINOGEN-ACTIVATORINHIBITOR-1 IN THE BLOOD OF PATIENTS WITH A PREVIOUS MYOCARDIAL-INFARCTION

      Coronary artery disease
    46. VAD H; TVEDSKOV TF; HANSEN KB; ALBRECHTSEN OK; JESPERSEN J; GRAM J
      ANTICOAGULANT PROPERTIES OF RABBIT LUNGS IN TISSUE THROMBOPLASTIN-INDUCED INTRAVASCULAR COAGULATION

      Thrombosis and haemostasis
    47. LARSEN LF; BLADBJERG EM; JESPERSEN J; MARCKMANN P
      EFFECTS OF DIETARY-FAT QUALITY AND QUANTITY ON POSTPRANDIAL ACTIVATION OF FACTOR-VII

      Thrombosis and haemostasis
    48. DEMAAT MPM; BLADBJERG EM; GRAM J; JOHANSEN LG; DEKNIJFF P; JESPERSEN J; KLUFT C
      PLASMA-LEVELS AND GENETIC POLYMORPHISMS OF VASCULAR-DISEASE RISK INDICATORS IN GREENLAND INUIT

      Thrombosis and haemostasis
    49. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) AN EVALUATION OF LYOPHILIZED PLASMAS FOR LOCAL ISI CALIBRATION

      Thrombosis and haemostasis
    50. HOUGHTON D; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; POLLER L
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) AN ASSESSMENT OF THE RELIABILITY OF A SIMPLIFIED METHOD OF STATISTICAL-ANALYSIS FOR LOCAL INR CORRECTION BASED ON LINEAR-REGRESSION

      Thrombosis and haemostasis
    51. HOUGHTON D; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; POLLER L
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) ECAA FIELD STUDIES OF LYOPHILIZED PLASMAS IN LOCAL PROTHROMBIN TIME (PT) SYSTEM ISI CALIBRATION

      Thrombosis and haemostasis
    52. GRAM J; DEMAAT MPM; JESPERSEN J; KLUFT C
      THE SSC SECONDARY COAGULATION STANDARD HAS THE POTENTIAL TO BE USED AS CALIBRATOR FOR SPECIFIC ANALYTES OF THE FIBRINOLYTIC SYSTEM

      Thrombosis and haemostasis
    53. MARCKMANN P; LARSEN LF; BENTZEN J; DEMAAT M; BLADBJERG EM; JESPERSEN J
      GENETIC INFLUENCE ON FACTOR-VII ACTIVATION FOLLOWING HIGH-SATURATED FAT MEALS

      Thrombosis and haemostasis
    54. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) THE MULTICENTER CALIBRATION OF RABBIT AND HUMAN ECAA REFERENCE THROMBOPLASTINS

      Thrombosis and haemostasis
    55. MYRUP B; JENSEN T; GRAM J; KLUFT C; JESPERSEN J; DECKERT T
      NO EFFECT OF UNFRACTIONED OR LOW-MOLECULAR-WEIGHT HEPARIN TREATMENT ON MARKERS OF VASCULAR WALL AND HEMOSTATIC FUNCTION IN INCIPIENT DIABETIC NEPHROPATHY

      Diabetes care
    56. DEMAAT MPM; BLADBJERG EM; JOHANSEN LG; BENTZEN J; JESPERSEN J
      PIA1 A2 POLYMORPHISM OF PLATELET GLYCOPROTEIN IIIA AND RISK OF CARDIOVASCULAR-DISEASE/

      Lancet
    57. SIDELMANN J; JESPERSEN J; KLUFT C; GRAM J
      THE EFFECT OF CHEMICAL ANTI-INHIBITORS ON FIBRINOLYTIC ENZYMES AND INHIBITORS

      Clinica chimica acta
    58. NIELSEN JD; GRAM J; HOLMNIELSEN A; FABRIN K; JESPERSEN J
      POSTOPERATIVE BLOOD-LOSS AFTER TRANSURETHRAL PROSTATECTOMY IS DEPENDENT ON IN-SITU FIBRINOLYSIS

      British Journal of Urology
    59. NIELSEN JD; GRAM J; FABRIN K; HOLMNIELSEN A; JESPERSEN J
      LACK OF CORRELATION BETWEEN BLOOD FIBRINOLYSIS AND THE IMMEDIATE OR POSTOPERATIVE BLOOD-LOSS IN TRANSURETHRAL RESECTION OF THE PROSTATE

      British Journal of Urology
    60. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      A SIMPLIFIED STATISTICAL-METHOD FOR LOCAL INR USING LINEAR-REGRESSION

      British Journal of Haematology
    61. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) ARTIFICIALLY DEPLETED LYOPHILIZED PLASMAS FOR ISI CALIBRATION

      Blood
    62. POLLER L; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) A COMPARATIVE-STUDY OF ARTIFICIALLY DEPLETED AND COUMARIN LYOPHILIZED PLASMAS FOR ISI CALIBRATION

      Blood
    63. POLLER L; HOUGHTON D; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) ECAA FIELD STUDIES OF LYOPHILIZED PLASMAS IN LOCAL PROTHROMBIN TIME (PT) SYSTEM ISI CALIBRATION

      Blood
    64. BLOEMENKAMP K; HELMERHORST F; JESPERSEN J; KLUFT C; SKOUBY S; HANNAFORD P; NORRIS L; ARCHER D; LIDEGAARD O; LUBSEN K; ROSENDAAL F; THOROGOOD M; VANDENBROUCKE J; BACK D; BRAKMAN O; FOTHERBY K; LEUVEN JG; HAMERLYNCK J; KUHL H; SAMSIOE G
      CONSENSUS DEVELOPMENT MEETING 1995 - COMBINED ORAL-CONTRACEPTIVES ANDCARDIOVASCULAR-DISEASE - THE CONSENSUS STATEMENT ISSUED AFTER THE 2NDEUROPEAN CONFERENCE ON SEX STEROIDS AND METABOLISM, AMSTERDAM, NOVEMBER 1995

      Gynecological endocrinology
    65. POLLER L; BARROWCLIFFE TW; VANDENBESSELAAR AMHP; JESPERSEN J; TRIPODI A; HOUGHTON D
      EUROPEAN CONCERTED ACTION ON ANTICOAGULATION (ECAA) - THE MULTICENTERCALIBRATION OF RABBIT AND HUMAN ECAA REFERENCE THROMBOPLASTINS

      Thrombosis and haemostasis
    66. MYRUP B; ROSSING P; JENSEN T; GRAM J; KLUFT C; JESPERSEN J
      FIBRINOLYSIS IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY

      Fibrinolysis
    67. JESPERSEN J; GRAM J
      INCREASED FIBRIN FORMATION IN BLOOD IN WOMEN ABOVE THE AGE OF 30 WHO ARE BOTH ORAL-CONTRACEPTIVE USERS AND SMOKERS

      Fibrinolysis
    68. SPANNAGL M; HENSELMANN P; WEBER M; GRAM J; JESPERSEN J; KLUFT C
      FACTOR-XII DEPENDENT FIBRINOLYTIC-ACTIVITY IS DECREASED IN THE ACUTE-PHASE OF MYOCARDIAL OR CEREBRAL INFARCTION

      Fibrinolysis
    69. GRAM J; JESPERSEN J; KLUFT C; DECLERCK P
      VARIOUS APPROACHES TO STANDARDIZATION AND THE IMPORTANCE OF MEASUREMENT ACCURACY

      Fibrinolysis
    70. PEDERSEN OD; SIDELMANN J; GRAM J; JESPERSEN J
      INFLUENCE OF BLOOD HANDLING ON DETERMINATION OF PLASMA RESISTANCE AGAINST ACTIVATED PROTEIN-C

      Fibrinolysis
    71. DEMAAT MPM; KLUFT C; JESPERSEN J; GRAM J
      WORLD DISTRIBUTION OF FACTOR-V LEIDEN MUTATION

      Lancet
    72. MARCKMANN P; NAWROTH P; WAHL P; JESPERSEN J
      DIET, GENDER, AND PLASMA THROMBOMODULIN

      Thrombosis research
    73. MYRUP B; DEMAAT M; ROSSING P; GRAM J; KLUFT C; JESPERSEN J
      ELEVATED FIBRINOGEN AND THE RELATION TO ACUTE-PHASE RESPONSE IN DIABETIC NEPHROPATHY

      Thrombosis research
    74. PETERSEN KR; KJEMS LL; SKOUBY SO; ANDERSEN LF; JESPERSEN J
      NO INFLUENCE OF PROINSULIN AND INSULIN ON PLASMA-LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TISSUE-PLASMINOGEN ACTIVATOR IN YOUNG-WOMEN BEFORE AND DURING INTAKE OF CONTRACEPTIVE STEROIDS

      Metabolism, clinical and experimental
    75. JUHANVAGUE I; PYKE SDM; ALESSI MC; JESPERSEN J; HAVERKATE F; THOMPSON SG
      FIBRINOLYTIC FACTORS AND THE RISK OF MYOCARDIAL-INFARCTION OR SUDDEN-DEATH IN PATIENTS WITH ANGINA-PECTORIS

      Circulation
    76. DEMAAT MPM; DEKNIJFF P; GREEN FR; THOMAS AE; JESPERSEN J; KLUFT C
      GENDER-RELATED ASSOCIATION BETWEEN BETA-FIBRINOGEN GENOTYPE AND PLASMA-FIBRINOGEN LEVELS AND LINKAGE DISEQUILIBRIUM AT THE FIBRINOGEN LOCUSIN GREENLAND INUIT

      Arteriosclerosis, thrombosis, and vascular biology
    77. SIDELMANN J; GRAM J; PEDERSEN OD; JESPERSEN J
      INFLUENCE OF PLASMA PLATELETS ON ACTIVATED PROTEIN-C RESISTANCE ASSAY

      Thrombosis and haemostasis
    78. GRAM J; SIDELMANN J; JESPERSEN J
      DOES LOW-PROTEIN CONCENTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PREDICT A LOW-RISK OF SPONTANEOUS DEEP-VEIN THROMBOSIS

      Thrombosis and haemostasis
    79. PEDERSEN OD; GRAM J; JESPERSEN J
      PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 DETERMINES PLASMIN FORMATION IN PATIENTS WITH ISCHEMIC-HEART-DISEASE

      Thrombosis and haemostasis
    80. BLADBJERG EM; THOLSTRUP T; MARCKMANN P; SANDSTROM B; JESPERSEN J
      DIETARY-CHANGES IN PASTING LEVELS OF FACTOR-VII COAGULANT ACTIVITY (FVII-C) ARE ACCOMPANIED BY CHANGES IN FACTOR-VII PROTEIN AND OTHER VITAMIN-K-DEPENDENT PROTEINS

      Thrombosis and haemostasis
    81. GRAM J; JESPERSEN J
      CHOLESTEROL-LOWERING, SIMVASTATIN, AND CORONARY HEART-DISEASE

      Lancet
    82. MYRUP B; HANSEN PM; JENSEN T; KOFOEDENEVOLDSEN A; FELDTRASMUSSEN B; GRAM J; KLUFT C; JESPERSEN J; DECKERT T
      EFFECT OF LOW-DOSE HEPARIN ON URINARY ALBUMIN EXCRETION IN INSULIN-DEPENDENT DIABETES-MELLITUS

      Lancet
    83. BLADBJERG EM; OVERGAARD K; GRAM J; JESPERSEN J
      THE PROTEIN-CONCENTRATION OF BLOOD-COAGULATION FACTOR-VII CAN BE MEASURED EQUALLY WELL IN PLASMA AND SERUM

      Scandinavian journal of clinical & laboratory investigation
    84. MYRUP B; ROSSING P; JENSEN T; GRAM J; KLUFT C; JESPERSEN J
      PROCOAGULANT ACTIVITY AND INTIMAL DYSFUNCTION IN IDDM

      Diabetologia
    85. SIDELMANN J; JESPERSEN J; GRAM J
      PLASMINOGEN-ACTIVATOR ACTIVITY AND PLASMA-COAGULUM LYSIS MEASURED BY USE OF OPTIMIZED FIBRIN GEL STRUCTURE PREFORMED IN MICROTITER PLATES

      Clinical chemistry
    86. DEMAAT MPM; JESPERSEN J; THOLSTRUP T; MARCKMANN P
      METHODS OF PLASMA-FIBRINOGEN MEASUREMENT AND DIETARY MODIFICATION - REPLY

      The American journal of clinical nutrition
    87. SORENSEN JD; SECHER NJ; JESPERSEN J
      PERTURBED (PROCOAGULANT) ENDOTHELIUM AND DEVIATIONS WITHIN THE FIBRINOLYTIC SYSTEM DURING THE 3RD TRIMESTER OF NORMAL-PREGNANCY - A POSSIBLE LINK TO PLACENTAL FUNCTION

      Acta obstetricia et gynecologica Scandinavica
    88. DEKNIJFF P; GREEN F; JOHANSEN LG; GROOTENDORST D; TEMPLE A; CRUICKSHANK JK; HUMPHRIES SE; JESPERSEN J; KLUFT C
      NEW ALLELES IN F7 VNTR

      Human molecular genetics
    89. PEDERSEN OD; GRAM J; BAGGER H; KELLER N; JESPERSEN J
      REGULATION OF TISSUE-TYPE PLASMINOGEN ACTIVATOR-MEDIATED FIBRINOLYSISBY PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PATIENTS WITH ISCHEMIC-HEART-DISEASE - POSSIBLE UNFAVORABLE EFFECT OF DIURETICS

      Coronary artery disease
    90. BLADBJERG EM; MARCKMANN P; SANDSTROM B; JESPERSEN J
      NONFASTING FACTOR-VII COAGULANT ACTIVITY (FVII C) INCREASED BY HIGH-FAT DIET/

      Thrombosis and haemostasis
    91. SORENSEN JD; OLSEN SF; SECHER NJ; JESPERSEN J
      EFFECTS OF FISH-OIL SUPPLEMENTATION IN LATE PREGNANCY ON BLOOD-LIPIDS, SERUM URATE, COAGULATION AND FIBRINOLYSIS - A RANDOMIZED CONTROLLED-STUDY (VOL 8, PG 54, 1994)

      Fibrinolysis
    92. SORENSEN JD; OLSEN SF; SECHER NJ; JESPERSEN J
      EFFECTS OF FISH-OIL SUPPLEMENTATION IN LATE PREGNANCY ON BLOOD-LIPIDS, SERUM URATE, COAGULATION AND FIBRINOLYSIS - A RANDOMIZED CONTROLLED-STUDY

      Fibrinolysis
    93. MYRUP B; ROSSING P; JENSEN T; GRAM J; KLUFT C; JESPERSEN J
      THE EFFECT OF THE RELATIONSHIP BETWEEN TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY IN INSULIN-DEPENDENT DIABETES-MELLITUS

      Fibrinolysis
    94. MARCKMANN P; JESPERSEN J
      INTRODUCTION TO DIET AND ENDOGENOUS FIBRINOLYSIS

      Fibrinolysis
    95. GRAM J; JESPERSEN J; DOOIJEWAARD G; KLUFT C
      THE EFFECT OF GLICLAZIDE ON PLASMA UROKINASE-RELATED FIBRINOLYSIS - THE RESULTS FROM AN EXPLORATORY-STUDY

      Fibrinolysis
    96. MARCKMANN P; JESPERSEN J
      ALPHA-LINOLENIC ACID AND REDUCTION OF CARDIAC DEATHS

      Lancet
    97. DEKNIJFF P; BOOMSMA DI; FESKENS EJM; JESPERSEN J; JOHANSEN LG; KLUFT C; KROMHOUT D; HAVEKES LM
      APOLIPOPROTEIN-E PHENOTYPE AND BLOOD-PRESSURE

      Lancet
    98. BLADBJERG EM; JESPERSEN J; GRAM J
      A NEW AUTOMATED-METHOD FOR CONTINUOUS REGISTRATION OF FACTOR-VII ACTIVATION IN-VITRO - ACTIVATION IS ACCELERATED BY THE CONCENTRATION OF FACTOR-VII AND THE ACTIVITY STATE OF THE PROTEIN

      Scandinavian journal of clinical & laboratory investigation
    99. BLADBJERG EM; JESPERSEN J; GRAM J
      A NEW AUTOMATED-METHOD FOR CONTINUOUS REGISTRATION OF FACTOR-VII ACTIVATION IN-VITRO - ACTIVATION IS ACCELERATED BY THE CONCENTRATION OF FACTOR-VII AND THE ACTIVITY STATE OF THE PROTEIN

      Scandinavian journal of clinical & laboratory investigation
    100. PETERSEN KR; SKOUBY SO; SIDELMANN J; JESPERSEN J
      ASSESSMENT OF ENDOTHELIAL FUNCTION DURING ORAL CONTRACEPTION IN WOMENWITH INSULIN-DEPENDENT DIABETES-MELLITUS

      Metabolism, clinical and experimental


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 07:35:34